Results 221 to 230 of about 134,137 (295)
THE ROLE OF IMMUNITY SUPPRESSION IN TREATMENT OF MYOCARDITIS
Anna Maria Frustaci +2 more
openalex +2 more sources
NT-proBNP serves as a prognostic marker for adverse outcomes in severe immune checkpoint inhibitor-associated myocarditis. [PDF]
He C, Xu L, Zhang Z, Wang J.
europepmc +1 more source
Systemic autoimmune diseases (sAIDs) affect 1 in 10 people and represent a leading cause of death in women under the age of 65 years. Despite the emergence of targeted‐biologic therapies, mortality rates for sAIDs have not improved. Emerging cellular therapies represent a promising therapeutic strategy for patients living with sAIDs given their ...
Elizabeth R. Volkmann +4 more
wiley +1 more source
Objective Digital gangrene is a severe complication of systemic sclerosis (SSc). This study aimed to examine the incidence and clinical associations of digital gangrene in patients with SSc after lung or heart–lung transplantation. Methods We performed a retrospective study of patients with SSc (SSc group) who underwent lung or heart–lung transplant ...
Brian S. Lee +4 more
wiley +1 more source
Mechanistic insights into COVID-19 mRNA vaccine-associated myocarditis: a bioinformatics analysis
Yanjie Jiang +3 more
openalex +1 more source
Absence of left ventricular dysfunction during acute chagasic myocarditis in the rhesus monkey. [PDF]
João A.C. Lima +7 more
openalex +1 more source
Schematic illustration of resident macrophages in Immune checkpoint inhibitor‐associated nephrotoxicity (ICI‐AN). Using an integrated approach (including imaging mass cytometry, transcriptomics, and murine models), this study reveals that resident macrophages drive immune‐stromal interactions in ICI‐AN, promoting fibroblast activation through CXCL9 and
Yanhong Ma +11 more
wiley +1 more source
Impact of low environmental temperatures on the global burden of myocarditis: insights from the 1990-2021 global burden of disease study. [PDF]
Ren Y, He Y, Hao Y, Yue Z, Zhu Z, Li X.
europepmc +1 more source

